Table 6. Cross-sectional associations with SBP in females at age 28 years.
Models | Beta | 95% CI | p-value |
Model 1 (n=483) | |||
BMI | 0.3 | 0.1-0.4 | 0.004 |
Height (cm) | 0.2 | 0.0-0.4 | 0.04 |
Uric acid | 22.1 | 4.7-39.5 | 0.01 |
Urine ACR > 3 mg/mmol | 6.3 | 1.6-11.0 | 0.008 |
(vs < 3 mg/mmol) | |||
Model R2 | 0.060 | ||
Model 1 + contraception use (n = 481) | |||
Combined oral contraceptive | 0.0 | -3.9-3.9 | 1.0 |
(vs no contraception) | |||
Intra-uterine device | -1.5 | -6.6-3.7 | 0.57 |
Injectables | 4.6 | 2.1-7.2 | < 0.001 |
Sterilisation | -0.6 | -14.3-13.2 | 0.93 |
Model R2 | 0.083 | ||
Model 1 + gestational hypertension (n=358) | |||
BMI | 0.1 | -0.1-0.3 | 0.47 |
Height (cm) | 0.2 | 0.0-0.4 | 0.03 |
Uric acid | 20.7 | 0.8-40.6 | 0.04 |
Urine ACR 3 mg/mmol | 7.6 | 2.5-12.7 | 0.003 |
(vs < 3 mg/mmol) | |||
Gestational hypertension (vs no gestational hypertension) | 9.5 | 6.2-12.8 | < 0.001 |
Model R2 | 0.133 |
BMI, body mass index; ACR, albumin:creatinine ratio.